Claritev Corp
Claritev is a technology, data and insights company that provides healthcare cost management and payment accuracy solutions. Its direct clients are typically healthcare payers, including administrative services only platforms and third-party administrators; employers, plan sponsors, health plan members and patients also use or benefit from its services. Claritev serves commercial and government healthcare payers, employers, brokers, providers and other organizations. It is headquartered in McLean, Virginia. Claritev offers four categories of solutions: Claims Intelligence, Network, Payment and Revenue Integrity, and Data and Analytics. Its offerings include out-of-network claim pricing and negotiation, provider networks and network management, claims reviews to identify improper charges, and analytics and transparency software. Clients use the solutions individually or in combination through Claritev’s platform. The company generally sells through payers and other distribution channels, and earns fees that include per-employee-per-month rates for some network services and a percentage of identified savings for certain network arrangements.
Piper Sandler raised its price target for Claritev (NYSE:CTEV) to $82, citing strong Q3 2026 results and raised full-year guidance. The stock has gained 14% over the past week. Claritev reported Q3 revenue of $268.3M, beating estimates, but posted an adjusted loss per share of $3.64. The company expects durable tailwinds from the No Surprises Act and maintains a 73% gross profit margin.
Claritev (CTEV) reported Q3 2026 results, raising its 2026 outlook and introducing preliminary 2027 revenue expectations of $1.1B. The company did not provide prior-period comparisons for the 2027 estimate.
Claritev Corporation (CTEV) introduced Transparency-Based Pricing, an AI-driven solution for payers and TPAs. The tool leverages public transparency data to enhance reimbursement intelligence, expanding the company's claims intelligence suite. Investors should monitor client adoption and revenue impact.
Over the past 7 days, AlphAI's AI scored 7 news stories mentioning CTEV (Claritev Corp). Coverage has skewed bullish: 4 bullish, 2 neutral, and 1 bearish.
Recent CTEV coverage spans corporate actions, earnings and financial news.
In the last 30 days, CTEV insiders filed 3 SEC Form 4 transactions — 2 purchases ($1.7M) and 1 sale ($138K). The most active reporter was ARES MANAGEMENT LLC with 2 filings. 33% of those filings were made under pre-arranged Rule 10b5-1 plans.
Target raise signals expected upside.
Guidance raise suggests stronger near‑term performance and may lift the stock.
The launch may generate incremental revenue if adopted, but impact is uncertain.
Small insider purchase may signal confidence but limited market impact.
The insider purchase may signal confidence and could provide modest upward pressure on the stock.
AlphAI scores every news story that mentions CTEV with an AI model for sentiment and relevance, and aggregates insider trades from Claritev Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.
Piper Sandler raised its price target for Claritev (NYSE:CTEV) to $82, citing strong Q3 2026 results and raised full-year guidance. The stock has gained 14% over the past week. Claritev reported Q3 revenue of $268.3M, beating estimates, but posted an adjusted loss per share of $3.64. The company expects durable tailwinds from the No Surprises Act and maintains a 73% gross profit margin.
Claritev (CTEV) reported Q3 2026 results, raising its 2026 outlook and introducing preliminary 2027 revenue expectations of $1.1B. The company did not provide prior-period comparisons for the 2027 estimate.
Claritev Corporation (CTEV) introduced Transparency-Based Pricing, an AI-driven solution for payers and TPAs. The tool leverages public transparency data to enhance reimbursement intelligence, expanding the company's claims intelligence suite. Investors should monitor client adoption and revenue impact.
ARES MANAGEMENT LLC purchased 70,834 indirectly-held shares of Claritev Corp (CTEV) at an average of $23.69 ($23.53–$24.07, $1.68M total) across 2 trades over 2026-10-23 to 2026-10-26. Filed jointly with ASOF II Holdings I, L.P. (10% owner), ASOF II A (DE) Holdings I, L.P. (10% owner) and ASOF III Holdings I LP (10% owner).
ARES MANAGEMENT LLC purchased 70,834 indirectly-held shares of Claritev Corp (CTEV) at an average of $23.69 ($23.53–$24.07, $1.68M total) across 2 trades over 2026-10-23 to 2026-10-26. Filed jointly with ASOF Investment Management LLC (10% owner), Ares Management Holdings L.P. (10% owner), Ares Holdco LLC (10% owner), Ares Management Corp (10% owner), Ares Voting LLC (10% owner), Ares Management GP LLC (10% owner) and Ares Partners Holdco LLC (10% owner).
Claritev (CTEV) appointed Jennifer Main to its Board and Audit Committee, effective October 15, 2026, while Jason Kap left the Audit Committee. The board expanded from 11 to 12 members, and Main will receive standard compensation and indemnification.
Claritev Corp (CTEV) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EXHIBIT 99.1 Claritev Appoints Jennifer Main to its Board of Directors Board gains deep public sector healthcare and financial leadership expertise to support Claritev's growth strategy McLean, VA — October 15, 2026 — Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV
Claritev Corporation was chosen by General Dynamics Information Technology (GDIT) to support the CDC's World Trade Center Health Program. Claritev will use its provider network to administer care for responders and survivors of 9/11, focusing on network development and provider access.
Claritev Corporation (NYSE: CTEV) appointed Ben Letham to its Board of Directors, effective September 14, 2026. Letham, a research scientist at Meta (Nasdaq: META), brings expertise in AI and optimization systems. The company aims to leverage his experience to support its AI-driven growth strategy in healthcare technology.
Claritev Corp (CTEV) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Claritev Appoints Ben Letham to its Board of Directors Board gains deep technology and innovation expertise to support Claritev’s tech-driven growth strategy McLean, VA — September 15, 2026 — Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data, and
